| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/12/2005 | CA2543945A1 Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid |
| 05/12/2005 | CA2543756A1 Hydroxypropyl amides for the treatment of alzheimer's disease |
| 05/12/2005 | CA2543745A1 Methods of organ regeneration |
| 05/12/2005 | CA2543710A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 05/12/2005 | CA2543436A1 Spirofuropyridine aryl derivatives |
| 05/12/2005 | CA2543322A1 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 05/12/2005 | CA2543242A1 Controlled release sterile injectable aripiprazole formulation and method |
| 05/12/2005 | CA2543122A1 3-(4-aminophenyl) thienopyrimid-4-one derivatives as mch r1 antagonists for the treatment of obesity, diabetes, depression and anxiety |
| 05/12/2005 | CA2542839A1 The use of ifenprodril in the treatment of pain |
| 05/12/2005 | CA2542837A1 The use of non-opiates for the potentiation of opiates |
| 05/12/2005 | CA2542752A1 Pharmaceutical compositions based on idazoxan salt or one of the polymorphs thereof |
| 05/12/2005 | CA2541852A1 Bone morphogenetic protein (bmp) 2a and uses thereof |
| 05/12/2005 | CA2540891A1 Use of extracts from the pelargonium species |
| 05/11/2005 | EP1529116A1 Methods for the treatment of dementia based on apo e genotype |
| 05/11/2005 | EP1529105A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 05/11/2005 | EP1529058A2 A non-selective cation channel in neural cells and methods for treating brain swelling |
| 05/11/2005 | EP1529055A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/11/2005 | EP1529049A2 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 05/11/2005 | EP1529048A2 Methods for the synthesis of substituted purines |
| 05/11/2005 | EP1529047A2 New purine derivatives |
| 05/11/2005 | EP1529046A1 Substituted benzimidazole compounds |
| 05/11/2005 | EP1529045A2 New compounds |
| 05/11/2005 | EP1529043A1 Novel process |
| 05/11/2005 | EP1529030A2 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
| 05/11/2005 | EP1528924A1 Mch1r antagonists |
| 05/11/2005 | EP1528923A1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
| 05/11/2005 | EP1528919A2 Therapeutic use of aryl amino acid derivatives |
| 05/11/2005 | EP1397363B1 5-ethyl-imidazotriazinones |
| 05/11/2005 | EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 05/11/2005 | EP1337532B1 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit |
| 05/11/2005 | EP1315480B1 "slow release" pharmaceutical compositions comprising lithium carbonate |
| 05/11/2005 | EP1289522B1 Medicaments for the adjuvant therapy of dementia comprising alpha lipoic acid |
| 05/11/2005 | EP1286590A4 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof |
| 05/11/2005 | EP1257526B1 Aniline-derived ligands for the thyroid receptor |
| 05/11/2005 | EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 05/11/2005 | EP1221952B1 Use of central cannabinoid receptor antagonist for preparing medicines |
| 05/11/2005 | EP1177790B1 Therapy with cannabinoids in the treatment of cerebral tumor |
| 05/11/2005 | EP1140124B1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
| 05/11/2005 | EP1128829B1 Riluzole and alpha-tocopherol combination |
| 05/11/2005 | EP1076563B1 Dipeptide caspase inhibitors and the use thereof |
| 05/11/2005 | EP1059930B1 Compositions comprising isovaleramide and ibuprofen |
| 05/11/2005 | EP1036092B1 Hydrophobically-modified hedgehog protein compositions and methods |
| 05/11/2005 | EP1019072B1 Method for assisting in differential diagnosis and treatment of autistic syndromes |
| 05/11/2005 | EP0971898B1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 05/11/2005 | EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/11/2005 | CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/11/2005 | CN1615357A Process for the manufacture of human mononuclear phagocytic leukocytes |
| 05/11/2005 | CN1615307A Process and intermediates for pyridazinone antidiabetic agents |
| 05/11/2005 | CN1615305A Coumarin derivatives, process for their production and use thereof |
| 05/11/2005 | CN1615297A Phenoxy piperidines for treating diseases such as schizophrenia and depression |
| 05/11/2005 | CN1615149A Drug mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/11/2005 | CN1615148A Methods and compositions for derepression of IAP-inhibited caspase |
| 05/11/2005 | CN1615144A A composition for treating neurocerebrovascular disorders |
| 05/11/2005 | CN1615140A Polynucleotide therapy |
| 05/11/2005 | CN1615134A Pharmaceutical compositions comprising valsartan and NEP inhibitors |
| 05/11/2005 | CN1615129A Process for affecting neurologic progression |
| 05/11/2005 | CN1615128A Preparation for improving the action of receptors |
| 05/11/2005 | CN1613482A Composition for improving memory and preparation thereof |
| 05/11/2005 | CN1613470A Paste |
| 05/11/2005 | CN1613468A Medical pillow |
| 05/11/2005 | CN1613467A Composition for restoring consciousness and improving memory quickly |
| 05/11/2005 | CN1613461A Arthralgia removing pills and their preparation |
| 05/11/2005 | CN1613447A Sustained released enteric soluble medicines |
| 05/11/2005 | CN1613443A Emodin application for preparaing medicine with nervous centralis erethism inhibition |
| 05/11/2005 | CN1200951C Process for productio nof multiple cross-linked hyaluronic acid derivatives |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/11/2005 | CN1200932C Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 05/11/2005 | CN1200931C Process for preparation of R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4- tetrahydrocarbazole |
| 05/11/2005 | CN1200930C New crystalline polymorphic form of 1-methyl-5-P-toluoylpyrroel-2-ac-etamidoacetic acid guaiacyl ester (MED 15) |
| 05/11/2005 | CN1200725C Traditional Chinese medicine for treating brain dysfunction and its producing method |
| 05/11/2005 | CN1200723C White peony and licorice extract and its prepn process |
| 05/11/2005 | CN1200722C Chinese medicinal powder for treating headache |
| 05/11/2005 | CN1200711C Nicotine delivery system |
| 05/11/2005 | CN1200710C New use of macrolide compound |
| 05/11/2005 | CN1200706C Compositions and methods for treating or preventing inflammatory diseases |
| 05/11/2005 | CN1200703C Use of pentanoate derivant |
| 05/11/2005 | CN1200700C Pharmaceutical tramadol salts |
| 05/11/2005 | CN1200699C Anthracyclinone derivatives and their use in amyloidosis |
| 05/11/2005 | CN1200697C Transnasal anticonvulsive compositions and modulated process |
| 05/11/2005 | CN1200691C Oral solution containing galanthamine and sweetening agent |
| 05/11/2005 | CN1200684C Compositions comprising organosiloxane resins for delivering oral care substances |
| 05/10/2005 | US6891066 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain |
| 05/10/2005 | US6891028 Nucleic acids encoding transferrin receptor-like proteins |
| 05/10/2005 | US6890959 Such as cis-(4-dimethylaminomethyl-3-hydroxy-3-(3-methoxy-phenyl)-cyclohexanone for treatment of pain, inflammation, allergies, depression, drug/alcohol abuse, gastritis, itching, cardiovascular/repiratory diseases, epilepsy, and diarrhea |
| 05/10/2005 | US6890956 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 05/10/2005 | US6890952 Administering cyclic substituted aminomethyl compounds for the preparation of a drug for the treatment of pain, urinary incotinence, itching, tinnitus aurium or diarrhea in a mammal |
| 05/10/2005 | US6890938 Antiinflammatory agents |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/10/2005 | US6890936 Muscarinic antagonists |
| 05/10/2005 | US6890935 Pharmaceutical compositions and methods for use |
| 05/10/2005 | US6890931 Methods of treating disorders with group I mGluR antagonists |
| 05/10/2005 | US6890929 Immunosuppressants; lupus, multiple sclerosis, skin disorders, antiarthritic agents, antihistamines, antiulcer agents, Crohn's disease |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/10/2005 | US6890927 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 05/10/2005 | US6890919 Atypical antipsychotic agents having low affinity for the D2 receptor |
| 05/10/2005 | US6890916 Indole derivatives useful for the treatment of CNS disorders |
| 05/10/2005 | US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 05/10/2005 | US6890914 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 05/10/2005 | US6890751 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/10/2005 | US6890532 Postexposure prophylaxis therapy |